MY8000108A - Substituted quidnazoline cardial stimulants - Google Patents

Substituted quidnazoline cardial stimulants

Info

Publication number
MY8000108A
MY8000108A MY1980108A MY8000108A MY8000108A MY 8000108 A MY8000108 A MY 8000108A MY 1980108 A MY1980108 A MY 1980108A MY 8000108 A MY8000108 A MY 8000108A MY 8000108 A MY8000108 A MY 8000108A
Authority
MY
Malaysia
Prior art keywords
quidnazoline
cardial
stimulants
substituted
substituted quidnazoline
Prior art date
Application number
MY1980108A
Other languages
English (en)
Inventor
Christopher Danilewicz John
Garth Evans Anthony
Leslie Ham Allan
Thomson Colin
Original Assignee
Pfizer Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Limited filed Critical Pfizer Limited
Publication of MY8000108A publication Critical patent/MY8000108A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
MY1980108A 1974-07-25 1980-12-31 Substituted quidnazoline cardial stimulants MY8000108A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB3280574 1974-07-25
GB41675*[A GB1460389A (en) 1974-07-25 1975-01-06 4-substituted quinazoline cardiac stimulants

Publications (1)

Publication Number Publication Date
MY8000108A true MY8000108A (en) 1980-12-31

Family

ID=26235904

Family Applications (1)

Application Number Title Priority Date Filing Date
MY1980108A MY8000108A (en) 1974-07-25 1980-12-31 Substituted quidnazoline cardial stimulants

Country Status (23)

Country Link
US (1) US4001422A (sk)
JP (1) JPS5527062B2 (sk)
AR (7) AR216046A1 (sk)
BG (2) BG27086A3 (sk)
CA (1) CA1060445A (sk)
CH (2) CH611616A5 (sk)
DD (1) DD119046A5 (sk)
DE (1) DE2530894C2 (sk)
DK (1) DK138800B (sk)
FI (1) FI66182C (sk)
FR (1) FR2279406A1 (sk)
GB (1) GB1460389A (sk)
HK (1) HK61879A (sk)
IE (1) IE41838B1 (sk)
IL (1) IL47625A (sk)
KE (1) KE2988A (sk)
LU (1) LU73072A1 (sk)
MY (1) MY8000108A (sk)
NL (1) NL159982C (sk)
PH (1) PH14190A (sk)
RO (3) RO69296A (sk)
SE (1) SE420921B (sk)
YU (3) YU37155B (sk)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN148482B (sk) 1977-06-03 1981-03-07 Pfizer
CA1086735A (en) * 1977-11-03 1980-09-30 John C. Danilewicz Piperidino-quinazolines
US4370328A (en) * 1977-11-03 1983-01-25 Pfizer Inc. Cardiac stimulant 1-(3- or 4-substituted piperidino)phthalazines
US4489075A (en) * 1982-05-15 1984-12-18 Pfizer Inc. Cyclic sulfonamidoalkyl substituted 4-piperidinoquinazoline cardiac stimulants
JPS61215389A (ja) * 1985-03-20 1986-09-25 Kyowa Hakko Kogyo Co Ltd キナゾリン誘導体およびそれを含有する強心剤
US6645969B1 (en) * 1991-05-10 2003-11-11 Aventis Pharmaceuticals Inc. Aryl and heteroaryl quinazoline compounds which inhibit CSF-1R receptor tyrosine kinase
FR2802206B1 (fr) * 1999-12-14 2005-04-22 Sod Conseils Rech Applic Derives de 4-aminopiperidine et leur utilisation en tant que medicament
TWI283665B (en) * 2001-09-13 2007-07-11 Smithkline Beecham Plc Novel urea compound, pharmaceutical composition containing the same and its use
HUP0200849A2 (hu) * 2002-03-06 2004-08-30 Sanofi-Synthelabo N-aminoacetil-2-ciano-pirrolidin-származékok, e vegyületeket tartalmazó gyógyszerkészítmények és eljárás előállításukra
US7064211B2 (en) * 2002-03-22 2006-06-20 Eisai Co., Ltd. Hemiasterlin derivatives and uses thereof
WO2004024710A1 (en) * 2002-09-13 2004-03-25 Glaxo Group Limited Urea compounds active as vanilloid receptor antagonists for the treatment of pain
TWI350168B (en) 2004-05-07 2011-10-11 Incyte Corp Amido compounds and their use as pharmaceuticals
NZ551603A (en) * 2004-06-24 2010-11-26 Incyte Corp N-substituted piperidines and their use as pharmaceuticals
US20060009471A1 (en) * 2004-06-24 2006-01-12 Wenqing Yao Amido compounds and their use as pharmaceuticals
JP2008504279A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション アミド化合物およびその医薬としての使用
JP2008504280A (ja) * 2004-06-24 2008-02-14 インサイト・コーポレイション ２−メチルプロパンアミドおよびその医薬としての使用
US20060019975A1 (en) * 2004-07-23 2006-01-26 Pfizer Inc Novel piperidyl derivatives of quinazoline and isoquinoline
MX2007001540A (es) * 2004-08-10 2007-04-23 Incyte Corp Compuestos amido y sus usos como farmaceuticos.
US8071768B2 (en) * 2005-06-10 2011-12-06 Janssen Pharmaceutica, N.V. Alkylquinoline and alkylquinazoline kinase modulators
US7825244B2 (en) * 2005-06-10 2010-11-02 Janssen Pharmaceutica Nv Intermediates useful in the synthesis of alkylquinoline and alkylquinazoline kinase modulators, and related methods of synthesis
TW200808807A (en) * 2006-03-02 2008-02-16 Incyte Corp Modulators of 11-β hydroxyl steroid dehydrogenase type 1, pharmaceutical compositions thereof, and methods of using the same
WO2007103719A2 (en) * 2006-03-03 2007-09-13 Incyte Corporation MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
CA2649677A1 (en) * 2006-05-01 2007-11-15 Incyte Corporation Tetrasubstituted ureas as modulators of 11-.beta. hydroxyl steroid dehydrogenase type 1
CA2652375A1 (en) * 2006-05-17 2007-11-29 Incyte Corporation Heterocyclic inhibitors of 11-.beta. hydroxyl steroid dehydrogenase type i and methods of using the same
EP1903038A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft N-(1-Hetaryl-piperidin-4-yl)-(het)arylamide als EP2-Rezeptor Modulatoren
EP1903037A1 (de) * 2006-09-07 2008-03-26 Bayer Schering Pharma Aktiengesellschaft 1-(Het)aryl-3-[hetaryl-piperidin-4-yl]-thioharnstoffe als Modulatoren des EP2-Rezeptors
SG11202108288YA (en) * 2019-02-01 2021-08-30 Univ Leland Stanford Junior Enpp1 inhibitors and methods of modulating immune response
WO2020190912A1 (en) 2019-03-19 2020-09-24 Stingray Therapeutics, Inc. Quinoline and quinazoline compounds and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1156973A (en) * 1965-07-06 1969-07-02 Quinazoline Derivatives
US3517005A (en) * 1967-10-26 1970-06-23 Pfizer & Co C Certain 2- and 4-substituted quinazolines
US3511836A (en) * 1967-12-13 1970-05-12 Pfizer & Co C 2,4,6,7-tetra substituted quinazolines
US3637701A (en) * 1969-03-03 1972-01-25 Sandoz Ag Certain nitrate derivatives of 4-aminoquinazolines
DE2121031A1 (en) * 1971-04-29 1972-11-02 Dr. Karl Thomae Gmbh, 7950 Biberach Base-substd quinazolines - thrombocyte aggregation inhibitors
BE793371A (fr) * 1971-12-27 1973-06-27 Sandoz Sa Nouveaux derives de la 4-amino-quinazoline, leur preparation etmedicaments contenant ces
US3819628A (en) * 1972-07-31 1974-06-25 Sandoz Ag 2-phenyl-4-substituted amino-quinazolines and nitrates thereof
US3838127A (en) * 1972-10-19 1974-09-24 Sandoz Ag 4-(4-(hydroxyalkyl)-1-piperazino)-quinazoline benzoates
GB1417029A (en) * 1973-03-07 1975-12-10 Pfizer Ltd Quinazoline-derived amines

Also Published As

Publication number Publication date
CH611616A5 (sk) 1979-06-15
RO69296A (ro) 1981-08-30
KE2988A (en) 1979-09-28
LU73072A1 (sk) 1977-03-24
YU124281A (en) 1983-04-30
NL159982C (nl) 1979-09-17
AR215882A1 (es) 1979-11-15
AR207895A1 (es) 1976-11-08
YU184275A (en) 1983-04-27
DK337175A (sk) 1976-01-26
IE41838B1 (en) 1980-04-09
DD119046A5 (sk) 1976-04-05
GB1460389A (en) 1977-01-06
DE2530894A1 (de) 1976-02-05
PH14190A (en) 1981-03-26
NL159982B (nl) 1979-04-17
RO71840A (ro) 1982-09-09
CH608803A5 (sk) 1979-01-31
YU124181A (en) 1983-04-30
AR216046A1 (es) 1979-11-30
SE420921B (sv) 1981-11-09
BG27744A3 (en) 1979-12-12
CA1060445A (en) 1979-08-14
FR2279406B1 (sk) 1980-04-30
FI752104A (sk) 1976-01-26
JPS5527062B2 (sk) 1980-07-17
AU8317475A (en) 1977-01-20
FR2279406A1 (fr) 1976-02-20
YU37155B (en) 1984-08-31
NL7508824A (nl) 1976-01-27
JPS5136469A (sk) 1976-03-27
IL47625A0 (en) 1975-10-15
BG27086A3 (bg) 1979-08-15
DE2530894C2 (de) 1983-12-22
DK138800C (sk) 1979-04-09
IE41838L (en) 1976-01-25
SE7508101L (sv) 1976-01-26
HK61879A (en) 1979-09-07
AR213407A1 (es) 1979-01-31
AR214050A1 (es) 1979-04-30
RO71841A (ro) 1980-08-15
AR212447A1 (es) 1978-07-14
FI66182C (fi) 1984-09-10
FI66182B (fi) 1984-05-31
DK138800B (da) 1978-10-30
IL47625A (en) 1981-01-30
US4001422A (en) 1977-01-04
AR214049A1 (es) 1979-04-30

Similar Documents

Publication Publication Date Title
MY8000108A (en) Substituted quidnazoline cardial stimulants
PH12506A (en) New pyridylguanidines
IL48592A0 (en) Novel 1-substituted-4-benzylpiperidine derivatives
IL48593A0 (en) Novel 1-substituted-4-benzylidenepiperidine derivatives
ZA753968B (en) Novel benzimidazolinone derivatives
ZA75357B (en) New phenol-acetals
EG11730A (en) New thiatiazolylimidazolidinones
IL48557A0 (en) Substituted ureido-compounds
US3992538A (en) Substituted o-acyl-acrylaldoximes
ZA752007B (en) Substituted triphenylethylenes
PH14623A (en) Substituted 1-sulfunylbenzimidazoles
AU7835575A (en) Substituted diaminoguanidines
IL46375A0 (en) Substituted tetrahydrobenzothiophenes
JPS5111725A (en) Torimechiru pp benzokinonnoseizoho
JPS5120688A (en) Roran c jushinkyo fuirutasochi
IL47350A0 (en) Substituted phenylmercapto-benzimidizoles
AU8293175A (en) Substituted hydroxyphenyl-piperidones
JPS5140373A (en) Monoooyobi * mataha jiisoshianeetoganjugasumataha jokikarakasuibunkainyorimonoooyobi * matahajiisoshianeetoo jokyosuru hoho
ZA751398B (en) New halo-pregnanes
IL47989A0 (en) New d-homo-steroids
JPS51105288A (en) Vor kokuenjohoshikinomogi vor shingomaakingusochiojusuruchijokyoku
ZA752689B (en) Substituted tetralins
JPS5126889A (en) Sefuarosuhorin c no saishuho
IL47988A0 (en) New d-homo-steroids
IL46149A0 (en) New thiadiazolylimidazolidinones